Global Gram-Negative Bacterial Infection Therapeutics Market Size, Status and Forecast 2023-2027

Report ID: 952852 | Published Date: Jan 2025 | No. of Page: 95 | Base Year: 2024 | Rating: 3.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Gram-Negative Bacterial Infection Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Enteral Treatment
        1.2.3 Parenteral Treatment
        1.2.4 Topical Treatment
    1.3 Market by Application
        1.3.1 Global Gram-Negative Bacterial Infection Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Gram-Negative Bacterial Infection Therapeutics Market Perspective (2016-2027)
    2.2 Gram-Negative Bacterial Infection Therapeutics Growth Trends by Regions
        2.2.1 Gram-Negative Bacterial Infection Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Gram-Negative Bacterial Infection Therapeutics Historic Market Share by Regions (2016-2021)
        2.2.3 Gram-Negative Bacterial Infection Therapeutics Forecasted Market Size by Regions (2022-2027)
    2.3 Gram-Negative Bacterial Infection Therapeutics Industry Dynamic
        2.3.1 Gram-Negative Bacterial Infection Therapeutics Market Trends
        2.3.2 Gram-Negative Bacterial Infection Therapeutics Market Drivers
        2.3.3 Gram-Negative Bacterial Infection Therapeutics Market Challenges
        2.3.4 Gram-Negative Bacterial Infection Therapeutics Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Gram-Negative Bacterial Infection Therapeutics Players by Revenue
        3.1.1 Global Top Gram-Negative Bacterial Infection Therapeutics Players by Revenue (2016-2021)
        3.1.2 Global Gram-Negative Bacterial Infection Therapeutics Revenue Market Share by Players (2016-2021)
    3.2 Global Gram-Negative Bacterial Infection Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Gram-Negative Bacterial Infection Therapeutics Revenue
    3.4 Global Gram-Negative Bacterial Infection Therapeutics Market Concentration Ratio
        3.4.1 Global Gram-Negative Bacterial Infection Therapeutics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Gram-Negative Bacterial Infection Therapeutics Revenue in 2020
    3.5 Gram-Negative Bacterial Infection Therapeutics Key Players Head office and Area Served
    3.6 Key Players Gram-Negative Bacterial Infection Therapeutics Product Solution and Service
    3.7 Date of Enter into Gram-Negative Bacterial Infection Therapeutics Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Gram-Negative Bacterial Infection Therapeutics Breakdown Data by Type
    4.1 Global Gram-Negative Bacterial Infection Therapeutics Historic Market Size by Type (2016-2021)
    4.2 Global Gram-Negative Bacterial Infection Therapeutics Forecasted Market Size by Type (2022-2027)

5 Gram-Negative Bacterial Infection Therapeutics Breakdown Data by Application
    5.1 Global Gram-Negative Bacterial Infection Therapeutics Historic Market Size by Application (2016-2021)
    5.2 Global Gram-Negative Bacterial Infection Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Gram-Negative Bacterial Infection Therapeutics Market Size (2016-2027)
    6.2 North America Gram-Negative Bacterial Infection Therapeutics Market Size by Type
        6.2.1 North America Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2016-2021)
        6.2.2 North America Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2022-2027)
        6.2.3 North America Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2016-2027)
    6.3 North America Gram-Negative Bacterial Infection Therapeutics Market Size by Application
        6.3.1 North America Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2016-2021)
        6.3.2 North America Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2022-2027)
        6.3.3 North America Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2016-2027)
    6.4 North America Gram-Negative Bacterial Infection Therapeutics Market Size by Country
        6.4.1 North America Gram-Negative Bacterial Infection Therapeutics Market Size by Country (2016-2021)
        6.4.2 North America Gram-Negative Bacterial Infection Therapeutics Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Gram-Negative Bacterial Infection Therapeutics Market Size (2016-2027)
    7.2 Europe Gram-Negative Bacterial Infection Therapeutics Market Size by Type
        7.2.1 Europe Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2016-2021)
        7.2.2 Europe Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2022-2027)
        7.2.3 Europe Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2016-2027)
    7.3 Europe Gram-Negative Bacterial Infection Therapeutics Market Size by Application
        7.3.1 Europe Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2016-2021)
        7.3.2 Europe Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2022-2027)
        7.3.3 Europe Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2016-2027)
    7.4 Europe Gram-Negative Bacterial Infection Therapeutics Market Size by Country
        7.4.1 Europe Gram-Negative Bacterial Infection Therapeutics Market Size by Country (2016-2021)
        7.4.2 Europe Gram-Negative Bacterial Infection Therapeutics Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Size (2016-2027)
    8.2 Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Size by Type
        8.2.1 Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2016-2027)
    8.3 Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Size by Application
        8.3.1 Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2016-2027)
    8.4 Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Size by Region
        8.4.1 Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Gram-Negative Bacterial Infection Therapeutics Market Size (2016-2027)
    9.2 Latin America Gram-Negative Bacterial Infection Therapeutics Market Size by Type
        9.2.1 Latin America Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2016-2021)
        9.2.2 Latin America Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2022-2027)
        9.2.3 Latin America Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2016-2027)
    9.3 Latin America Gram-Negative Bacterial Infection Therapeutics Market Size by Application
        9.3.1 Latin America Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2016-2021)
        9.3.2 Latin America Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2022-2027)
        9.3.3 Latin America Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2016-2027)
    9.4 Latin America Gram-Negative Bacterial Infection Therapeutics Market Size by Country
        9.4.1 Latin America Gram-Negative Bacterial Infection Therapeutics Market Size by Country (2016-2021)
        9.4.2 Latin America Gram-Negative Bacterial Infection Therapeutics Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size (2016-2027)
    10.2 Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size by Type
        10.2.1 Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2016-2027)
    10.3 Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size by Application
        10.3.1 Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2016-2027)
    10.4 Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size by Country
        10.4.1 Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Baxter
        11.1.1 Baxter Company Details
        11.1.2 Baxter Business Overview
        11.1.3 Baxter Gram-Negative Bacterial Infection Therapeutics Introduction
        11.1.4 Baxter Revenue in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021)
        11.1.5 Baxter Recent Development
    11.2 Sanofi
        11.2.1 Sanofi Company Details
        11.2.2 Sanofi Business Overview
        11.2.3 Sanofi Gram-Negative Bacterial Infection Therapeutics Introduction
        11.2.4 Sanofi Revenue in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021)
        11.2.5 Sanofi Recent Development
    11.3 GlaxoSmithKline
        11.3.1 GlaxoSmithKline Company Details
        11.3.2 GlaxoSmithKline Business Overview
        11.3.3 GlaxoSmithKline Gram-Negative Bacterial Infection Therapeutics Introduction
        11.3.4 GlaxoSmithKline Revenue in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021)
        11.3.5 GlaxoSmithKline Recent Development
    11.4 Novartis
        11.4.1 Novartis Company Details
        11.4.2 Novartis Business Overview
        11.4.3 Novartis Gram-Negative Bacterial Infection Therapeutics Introduction
        11.4.4 Novartis Revenue in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021)
        11.4.5 Novartis Recent Development
    11.5 Pfizer
        11.5.1 Pfizer Company Details
        11.5.2 Pfizer Business Overview
        11.5.3 Pfizer Gram-Negative Bacterial Infection Therapeutics Introduction
        11.5.4 Pfizer Revenue in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021)
        11.5.5 Pfizer Recent Development
    11.6 Takeda
        11.6.1 Takeda Company Details
        11.6.2 Takeda Business Overview
        11.6.3 Takeda Gram-Negative Bacterial Infection Therapeutics Introduction
        11.6.4 Takeda Revenue in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021)
        11.6.5 Takeda Recent Development
    11.7 Nektar Therapeutics
        11.7.1 Nektar Therapeutics Company Details
        11.7.2 Nektar Therapeutics Business Overview
        11.7.3 Nektar Therapeutics Gram-Negative Bacterial Infection Therapeutics Introduction
        11.7.4 Nektar Therapeutics Revenue in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021)
        11.7.5 Nektar Therapeutics Recent Development
    11.8 Sumitomo
        11.8.1 Sumitomo Company Details
        11.8.2 Sumitomo Business Overview
        11.8.3 Sumitomo Gram-Negative Bacterial Infection Therapeutics Introduction
        11.8.4 Sumitomo Revenue in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021)
        11.8.5 Sumitomo Recent Development
    11.9 Targeted Genetics
        11.9.1 Targeted Genetics Company Details
        11.9.2 Targeted Genetics Business Overview
        11.9.3 Targeted Genetics Gram-Negative Bacterial Infection Therapeutics Introduction
        11.9.4 Targeted Genetics Revenue in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021)
        11.9.5 Targeted Genetics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Gram-Negative Bacterial Infection Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Enteral Treatment
    Table 3. Key Players of Parenteral Treatment
    Table 4. Key Players of Topical Treatment
    Table 5. Global Gram-Negative Bacterial Infection Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Gram-Negative Bacterial Infection Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Gram-Negative Bacterial Infection Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
    Table 8. Global Gram-Negative Bacterial Infection Therapeutics Market Share by Regions (2016-2021)
    Table 9. Global Gram-Negative Bacterial Infection Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 10. Global Gram-Negative Bacterial Infection Therapeutics Market Share by Regions (2022-2027)
    Table 11. Gram-Negative Bacterial Infection Therapeutics Market Trends
    Table 12. Gram-Negative Bacterial Infection Therapeutics Market Drivers
    Table 13. Gram-Negative Bacterial Infection Therapeutics Market Challenges
    Table 14. Gram-Negative Bacterial Infection Therapeutics Market Restraints
    Table 15. Global Gram-Negative Bacterial Infection Therapeutics Revenue by Players (2016-2021) & (US$ Million)
    Table 16. Global Gram-Negative Bacterial Infection Therapeutics Market Share by Players (2016-2021)
    Table 17. Global Top Gram-Negative Bacterial Infection Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gram-Negative Bacterial Infection Therapeutics as of 2020)
    Table 18. Ranking of Global Top Gram-Negative Bacterial Infection Therapeutics Companies by Revenue (US$ Million) in 2020
    Table 19. Global 5 Largest Players Market Share by Gram-Negative Bacterial Infection Therapeutics Revenue (CR5 and HHI) & (2016-2021)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Gram-Negative Bacterial Infection Therapeutics Product Solution and Service
    Table 22. Date of Enter into Gram-Negative Bacterial Infection Therapeutics Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 25. Global Gram-Negative Bacterial Infection Therapeutics Revenue Market Share by Type (2016-2021)
    Table 26. Global Gram-Negative Bacterial Infection Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 27. Global Gram-Negative Bacterial Infection Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 28. Global Gram-Negative Bacterial Infection Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
    Table 29. Global Gram-Negative Bacterial Infection Therapeutics Revenue Market Share by Application (2016-2021)
    Table 30. Global Gram-Negative Bacterial Infection Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 31. Global Gram-Negative Bacterial Infection Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 32. North America Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 33. North America Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 34. North America Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 35. North America Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 36. North America Gram-Negative Bacterial Infection Therapeutics Market Size by Country (2016-2021) & (US$ Million) 
    Table 37. North America Gram-Negative Bacterial Infection Therapeutics Market Size by Country (2022-2027) & (US$ Million) 
    Table 38. Europe Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 39. Europe Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 40. Europe Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 41. Europe Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 42. Europe Gram-Negative Bacterial Infection Therapeutics Market Size by Country (2016-2021) & (US$ Million) 
    Table 43. Europe Gram-Negative Bacterial Infection Therapeutics Market Size by Country (2022-2027) & (US$ Million) 
    Table 44. Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 45. Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 46. Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 47. Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 48. Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Size by Region (2016-2021) & (US$ Million) 
    Table 49. Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Size by Region (2022-2027) & (US$ Million) 
    Table 50. Latin America Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 51. Latin America Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 52. Latin America Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 53. Latin America Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 54. Latin America Gram-Negative Bacterial Infection Therapeutics Market Size by Country (2016-2021) & (US$ Million) 
    Table 55. Latin America Gram-Negative Bacterial Infection Therapeutics Market Size by Country (2022-2027) & (US$ Million) 
    Table 56. Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 57. Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 58. Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 59. Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 60. Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size by Country (2016-2021) & (US$ Million) 
    Table 61. Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size by Country (2022-2027) & (US$ Million) 
    Table 62. Baxter Company Details
    Table 63. Baxter Business Overview
    Table 64. Baxter Gram-Negative Bacterial Infection Therapeutics Product
    Table 65. Baxter Revenue in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021) & (US$ Million)
    Table 66. Baxter Recent Development
    Table 67. Sanofi Company Details
    Table 68. Sanofi Business Overview
    Table 69. Sanofi Gram-Negative Bacterial Infection Therapeutics Product
    Table 70. Sanofi Revenue in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021) & (US$ Million)
    Table 71. Sanofi Recent Development
    Table 72. GlaxoSmithKline Company Details
    Table 73. GlaxoSmithKline Business Overview
    Table 74. GlaxoSmithKline Gram-Negative Bacterial Infection Therapeutics Product
    Table 75. GlaxoSmithKline Revenue in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021) & (US$ Million)
    Table 76. GlaxoSmithKline Recent Development
    Table 77. Novartis Company Details
    Table 78. Novartis Business Overview
    Table 79. Novartis Gram-Negative Bacterial Infection Therapeutics Product
    Table 80. Novartis Revenue in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021) & (US$ Million)
    Table 81. Novartis Recent Development
    Table 82. Pfizer Company Details
    Table 83. Pfizer Business Overview
    Table 84. Pfizer Gram-Negative Bacterial Infection Therapeutics Product
    Table 85. Pfizer Revenue in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021) & (US$ Million)
    Table 86. Pfizer Recent Development
    Table 87. Takeda Company Details
    Table 88. Takeda Business Overview
    Table 89. Takeda Gram-Negative Bacterial Infection Therapeutics Product
    Table 90. Takeda Revenue in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021) & (US$ Million)
    Table 91. Takeda Recent Development
    Table 92. Nektar Therapeutics Company Details
    Table 93. Nektar Therapeutics Business Overview
    Table 94. Nektar Therapeutics Gram-Negative Bacterial Infection Therapeutics Product
    Table 95. Nektar Therapeutics Revenue in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021) & (US$ Million)
    Table 96. Nektar Therapeutics Recent Development
    Table 97. Sumitomo Company Details
    Table 98. Sumitomo Business Overview
    Table 99. Sumitomo Revenue in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021) & (US$ Million)
    Table 100. Sumitomo Recent Development
    Table 101. Targeted Genetics Company Details
    Table 102. Targeted Genetics Business Overview
    Table 103. Targeted Genetics Gram-Negative Bacterial Infection Therapeutics Product
    Table 104. Targeted Genetics Revenue in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021) & (US$ Million)
    Table 105. Targeted Genetics Recent Development
    Table 106. Research Programs/Design for This Report
    Table 107. Key Data Information from Secondary Sources
    Table 108. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Gram-Negative Bacterial Infection Therapeutics Market Share by Type: 2020 VS 2027
    Figure 2. Enteral Treatment Features
    Figure 3. Parenteral Treatment Features
    Figure 4. Topical Treatment Features
    Figure 5. Global Gram-Negative Bacterial Infection Therapeutics Market Share by Application: 2020 VS 2027
    Figure 6. Hospitals Case Studies
    Figure 7. Clinics Case Studies
    Figure 8. Others Case Studies
    Figure 9. Gram-Negative Bacterial Infection Therapeutics Report Years Considered
    Figure 10. Global Gram-Negative Bacterial Infection Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 11. Global Gram-Negative Bacterial Infection Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 12. Global Gram-Negative Bacterial Infection Therapeutics Market Share by Regions: 2020 VS 2027
    Figure 13. Global Gram-Negative Bacterial Infection Therapeutics Market Share by Regions (2022-2027)
    Figure 14. Global Gram-Negative Bacterial Infection Therapeutics Market Share by Players in 2020
    Figure 15. Global Top Gram-Negative Bacterial Infection Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gram-Negative Bacterial Infection Therapeutics as of 2020
    Figure 16. The Top 10 and 5 Players Market Share by Gram-Negative Bacterial Infection Therapeutics Revenue in 2020
    Figure 17. Global Gram-Negative Bacterial Infection Therapeutics Revenue Market Share by Type (2016-2021)
    Figure 18. Global Gram-Negative Bacterial Infection Therapeutics Revenue Market Share by Type (2022-2027)
    Figure 19. North America Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 20. North America Gram-Negative Bacterial Infection Therapeutics Market Share by Type (2016-2027)
    Figure 21. North America Gram-Negative Bacterial Infection Therapeutics Market Share by Application (2016-2027)
    Figure 22. North America Gram-Negative Bacterial Infection Therapeutics Market Share by Country (2016-2027)
    Figure 23. United States Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Canada Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Europe Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Europe Gram-Negative Bacterial Infection Therapeutics Market Share by Type (2016-2027)
    Figure 27. Europe Gram-Negative Bacterial Infection Therapeutics Market Share by Application (2016-2027)
    Figure 28. Europe Gram-Negative Bacterial Infection Therapeutics Market Share by Country (2016-2027)
    Figure 29. Germany Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. France Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. U.K. Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Italy Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Russia Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Nordic Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Share by Type (2016-2027)
    Figure 37. Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Share by Application (2016-2027)
    Figure 38. Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Share by Region (2016-2027)
    Figure 39. China Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. Japan Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. South Korea Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Southeast Asia Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. India Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Australia Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Latin America Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Latin America Gram-Negative Bacterial Infection Therapeutics Market Share by Type (2016-2027)
    Figure 47. Latin America Gram-Negative Bacterial Infection Therapeutics Market Share by Application (2016-2027)
    Figure 48. Latin America Gram-Negative Bacterial Infection Therapeutics Market Share by Country (2016-2027)
    Figure 49. Mexico Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Brazil Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Share by Type (2016-2027)
    Figure 53. Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Share by Application (2016-2027)
    Figure 54. Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Share by Country (2016-2027)
    Figure 55. Turkey Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. Saudi Arabia Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. UAE Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. Baxter Revenue Growth Rate in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021)
    Figure 59. Sanofi Revenue Growth Rate in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021)
    Figure 60. GlaxoSmithKline Revenue Growth Rate in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021)
    Figure 61. Novartis Revenue Growth Rate in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021)
    Figure 62. Pfizer Revenue Growth Rate in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021)
    Figure 63. Takeda Revenue Growth Rate in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021)
    Figure 64. Nektar Therapeutics Revenue Growth Rate in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021)
    Figure 65. Sumitomo Revenue Growth Rate in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021)
    Figure 66. Targeted Genetics Revenue Growth Rate in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021)
    Figure 67. Bottom-up and Top-down Approaches for This Report
    Figure 68. Data Triangulation
    Figure 69. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Baxter
Sanofi
GlaxoSmithKline
Novartis
Pfizer
Takeda
Nektar Therapeutics
Sumitomo
Targeted Genetics
Frequently Asked Questions
Gram-Negative Bacterial Infection Therapeutics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Gram-Negative Bacterial Infection Therapeutics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Gram-Negative Bacterial Infection Therapeutics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Bone Density Testing

Bone density testing provides more high-level overview and in-depth details on more specific aspe ... Read More